980 related articles for article (PubMed ID: 28640706)
1. Adult Glioblastoma.
Alexander BM; Cloughesy TF
J Clin Oncol; 2017 Jul; 35(21):2402-2409. PubMed ID: 28640706
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers and therapeutic advances in glioblastoma multiforme.
Sasmita AO; Wong YP; Ling APK
Asia Pac J Clin Oncol; 2018 Feb; 14(1):40-51. PubMed ID: 28840962
[TBL] [Abstract][Full Text] [Related]
3. Epithelioid/rhabdoid glioblastoma: a highly aggressive subtype of glioblastoma.
Sugimoto K; Ideguchi M; Kimura T; Kajiwara K; Imoto H; Sadahiro H; Ishii A; Kawano H; Ikeda E; Suzuki M
Brain Tumor Pathol; 2016 Apr; 33(2):137-46. PubMed ID: 26667174
[TBL] [Abstract][Full Text] [Related]
4. Glioblastoma biomarkers from bench to bedside: advances and challenges.
Farias-Eisner G; Bank AM; Hwang BY; Appelboom G; Piazza MA; Bruce SS; Sander Connolly E
Br J Neurosurg; 2012 Apr; 26(2):189-94. PubMed ID: 22176646
[TBL] [Abstract][Full Text] [Related]
5. Advances and challenges in the treatment of glioblastoma: a clinician's perspective.
Mrugala MM
Discov Med; 2013 Apr; 15(83):221-30. PubMed ID: 23636139
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of multifocal and multicentric glioblastoma.
Li Y; Zhang ZX; Huang GH; Xiang Y; Yang L; Pei YC; Yang W; Lv SQ
J Clin Neurosci; 2021 Jan; 83():71-76. PubMed ID: 33358091
[TBL] [Abstract][Full Text] [Related]
7. From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence.
Zygogianni A; Protopapa M; Kougioumtzopoulou A; Simopoulou F; Nikoloudi S; Kouloulias V
Clin Transl Oncol; 2018 Aug; 20(8):989-1003. PubMed ID: 29335830
[TBL] [Abstract][Full Text] [Related]
8. AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme.
Chinot OL; de La Motte Rouge T; Moore N; Zeaiter A; Das A; Phillips H; Modrusan Z; Cloughesy T
Adv Ther; 2011 Apr; 28(4):334-40. PubMed ID: 21432029
[TBL] [Abstract][Full Text] [Related]
9. Recent and ongoing clinical trials in glioblastoma.
Lombardi G
Clin Adv Hematol Oncol; 2018 Jul; 16(7):480-483. PubMed ID: 30067618
[No Abstract] [Full Text] [Related]
10. Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).
Bryukhovetskiy I; Ponomarenko A; Lyakhova I; Zaitsev S; Zayats Y; Korneyko M; Eliseikina M; Mischenko P; Shevchenko V; Shanker Sharma H; Sharma A; Khotimchenko Y
Int J Mol Med; 2018 Aug; 42(2):691-702. PubMed ID: 29749540
[TBL] [Abstract][Full Text] [Related]
11. Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments.
Kesari S
Semin Oncol; 2011 Dec; 38 Suppl 4():S2-10. PubMed ID: 22078644
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors.
Schäfer N; Gielen GH; Rauschenbach L; Kebir S; Till A; Reinartz R; Simon M; Niehusmann P; Kleinschnitz C; Herrlinger U; Pietsch T; Scheffler B; Glas M
J Transl Med; 2019 Mar; 17(1):96. PubMed ID: 30894200
[TBL] [Abstract][Full Text] [Related]
13. Present and Future of Anti-Glioblastoma Therapies: A Deep Look into Molecular Dependencies/Features.
Kim HJ; Kim DY
Molecules; 2020 Oct; 25(20):. PubMed ID: 33053763
[TBL] [Abstract][Full Text] [Related]
14. Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary.
Jarzabek MA; Sweeney KJ; Evans RL; Jacobs AH; Stupp R; O'Brien D; Berger MS; Prehn JH; Byrne AT
Drug Discov Today; 2013 Nov; 18(21-22):1052-66. PubMed ID: 23792334
[TBL] [Abstract][Full Text] [Related]
15. Glioblastoma multiforme: a review of therapeutic targets.
Kanu OO; Mehta A; Di C; Lin N; Bortoff K; Bigner DD; Yan H; Adamson DC
Expert Opin Ther Targets; 2009 Jun; 13(6):701-18. PubMed ID: 19409033
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic markers for glioblastoma.
Jung CS; Unterberg AW; Hartmann C
Histol Histopathol; 2011 Oct; 26(10):1327-41. PubMed ID: 21870336
[TBL] [Abstract][Full Text] [Related]
17. Treatment and survival of patients harboring histological variants of glioblastoma.
Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive profile of recurrent glioblastoma.
Campos B; Olsen LR; Urup T; Poulsen HS
Oncogene; 2016 Nov; 35(45):5819-5825. PubMed ID: 27041580
[TBL] [Abstract][Full Text] [Related]
19. Neuroimaging: diagnosis and response assessment in glioblastoma.
Clarke JL; Chang SM
Cancer J; 2012; 18(1):26-31. PubMed ID: 22290254
[TBL] [Abstract][Full Text] [Related]
20. Impact of tumor infiltrating CD63 positive cells on survival in patients with glioblastoma multiforme.
Kase M; Adamson A; Saretok M; Minajeva A; Vardja M; Jõgi T; Asser T; Jaal J
J Neurosurg Sci; 2016 Dec; 60(4):417-23. PubMed ID: 25215582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
